Torray Investment Partners LLC boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 38.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,305 shares of the semiconductor company’s stock after purchasing an additional 4,546 shares during the quarter. Torray Investment Partners LLC’s holdings in Synopsys were worth $7,914,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Hazlett Burt & Watson Inc. boosted its position in shares of Synopsys by 40.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares in the last quarter. Caprock Group LLC boosted its holdings in Synopsys by 0.5% in the fourth quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company’s stock worth $1,803,000 after acquiring an additional 20 shares in the last quarter. Compagnie Lombard Odier SCmA grew its stake in Synopsys by 1.1% in the fourth quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company’s stock valued at $898,000 after acquiring an additional 20 shares during the period. Edge Capital Group LLC grew its stake in Synopsys by 1.2% in the fourth quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company’s stock valued at $791,000 after acquiring an additional 20 shares during the period. Finally, Aptus Capital Advisors LLC raised its position in shares of Synopsys by 1.5% during the third quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock worth $733,000 after purchasing an additional 22 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.62% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Stock Analysis on SNPS
Synopsys Price Performance
NASDAQ SNPS opened at $443.26 on Tuesday. The business’s fifty day moving average is $505.15 and its 200-day moving average is $514.75. The stock has a market capitalization of $68.54 billion, a price-to-earnings ratio of 30.53, a PEG ratio of 3.23 and a beta of 1.12. Synopsys, Inc. has a one year low of $442.29 and a one year high of $624.80.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Overbought Stocks Explained: Should You Trade Them?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- How to Short a Stock in 5 Easy StepsĀ
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- The How And Why of Investing in Oil Stocks
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.